Short answer
Healthcare rises on strong drug pipelines, favourable Medicare pricing news, or as a defensive shift when the economy slows.
Healthcare rises on strong drug pipelines, favourable Medicare pricing news, or as a defensive shift when the economy slows.
The Health Care Select Sector ETF (XLV) climbed, led by big pharma and med-tech.
Weight-loss drugs (GLP-1s from Eli Lilly and Novo Nordisk) are reshaping the sector. Aging populations also mean structural demand.
Healthcare is defensive and roughly 13% of the S&P 500.
New drugs and technologies eventually affect what your insurer covers.
Most analysts expect the market to expand for years — new indications keep being approved.
This is an affiliate link. If you sign up, YourBet.ai may earn a commission — at no extra cost to you. We only feature providers we believe are relevant for anyone. Not financial advice.